Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
about
Radionecrosis after stereotactic radiotherapy for brain metastases.[Melanoma brain metastases : Treatment options].A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis.Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis.Radiotoxicity in robotic radiosurgery: proposing a new quality index for optimizing the treatment planning of brain metastases.The radiosurgery fractionation quandary: single fraction or hypofractionation?Prospective study of 11C-methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment.Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy.Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of Lung Cancer Brain Metastases to Stereotactic Radiosurgery.Brain metastases: neuroimaging.Fractionation enhances acute oligodendrocyte progenitor cell radiation sensitivity and leads to long term depletion.Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.Understanding the continuum of radionecrosis and vascular disorders in the brain following gamma knife irradiation: An MRI study.Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.Melanoma Brain Metastases: Local Therapies, Targeted Therapies, Immune Checkpoint Inhibitors and Their Combinations-Chances and Challenges.Effect of Gamma Knife Radiosurgery and Programmed Cell Death 1 Receptor Antagonists on Metastatic Melanoma.Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.Institutional experience with SRS VMAT planning for multiple cranial metastases.[Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases].Mechanisms and Therapy for Cancer Metastasis to the Brain.Second course of stereotactic radiosurgery for locally recurrent brain metastases: Safety and efficacy.Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumabOutcomes of Metastatic Brain Lesions Treated with Radioactive Cs-131 Seeds after Surgery: Experience from One InstitutionDiagnosis and Management of Radiation Necrosis in Patients With Brain MetastasesBrain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgeryBrain Radiation Necrosis: Current Management With a Focus on Non-small Cell Lung Cancer PatientsCombined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis
P2860
Q31095955-259EC525-7BBF-428F-830B-13ACB86CE0FDQ31098294-FBAECF1F-9AAD-416D-B6E2-5445C9D29BCDQ36280675-ED8B4BCB-C7B6-4D1C-9DFE-6055110CB5EBQ38803916-CDC38A8B-799A-47A1-9C90-29AF800947E3Q41451038-38EF90EB-3A4A-4454-9618-A936A17FB443Q44455124-DE090C33-2556-4852-8944-DF21F692F810Q47109146-81FD11E3-B939-41D8-B399-D56895B4780FQ47768004-A8E95902-1FDC-4529-BA3E-624DE9D12795Q47827501-95FA0587-1411-44A4-833C-80F068249D03Q47879878-117B5AEF-D5FA-47E2-B164-3324D2FEAD7FQ47890016-4CA0B546-A893-451F-8212-54B472177DDCQ47989008-7F5B974B-3499-46D2-80DA-ABF61E000869Q48213133-CF97B862-465C-416A-95A1-24610217C609Q48428404-D239C0D3-4192-4360-9C42-7FCF341994A8Q48597385-B9CF0B59-897B-48F8-96EB-C212E91CE582Q50125923-B2785964-5564-4B4D-AC3C-621BE3A4C9B8Q50422388-9835EA87-1EC7-4747-9954-28D30559D61DQ50651030-9258DAF8-03EC-4237-A91F-E8AA8752DA0EQ52687492-14E23DFB-6285-44CD-8AC8-9CA87868D1ADQ53180522-5220B24D-6D31-4256-8069-11876CFEDD55Q54950354-20ED0764-1859-406D-ABCB-2EA7BA13570EQ55314727-4456626A-35C7-4FAF-BB28-162AA9C61A0DQ56889910-4AB6F1DB-D7C7-4922-8146-20BC488705A4Q57138119-F8DD0C70-24DE-42EE-ADD2-D1FC51B258F5Q57490209-A63E59B1-F3DF-46DA-9E33-ACB4469EE8D3Q58131342-B4948C02-66BF-4B07-8375-29C2F9BB9A38Q58762991-DC479AD1-2E84-469D-A005-F46EB3D5FD8DQ58766238-74F51BB9-B511-44D4-A2DA-F1BDD3FFD29F
P2860
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@ast
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@en
type
label
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@ast
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@en
prefLabel
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@ast
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@en
P2093
P2860
P50
P1476
Long-term risk of radionecrosi ...... osurgery for brain metastases.
@en
P2093
Kathryn Beal
Marc K Rosenblum
Philip H Gutin
T Jonathan Yang
Timothy A Chan
Yoshiya Yamada
Zhigang Zhang
Åse Ballangrud
P2860
P2888
P304
P356
10.1007/S11060-015-1881-3
P577
2015-08-26T00:00:00Z